Lung Cancer Session · lung cancer, colorectal cancer, sarcomas, and all other solid tumors. He has overall 26 years of professional experience. ... an internationally recognised

16th October 202017:00 Hrs - 21:10 Hrs UAE Time

VIRTUAL CONGRESS

CLICK HERE TO REGISTER

Lung Cancer SessionE - BROCHURE

2


Alona ZerRabin Medical Center, Israel

Byoung Chul ChoYonsei University College of Medicine South Korea

Alfredo AddeoGeneva University Hospital, SwitzerlandDr. Alfredo Addeo is a senior oncologist at the Geneva University Hospital, Geneva Switzerland. Dr. Addeo received his training at the University of Turin (Italy)and completed a MD in oncology at the University school of medicine of Turin (Italy). He is the lead for several translational research project his department: his main interests at the moment are liquid biopsy, ctDNA and TMB in thoracic malignancies.

Dr. Alona Zer is affiliated to Rabin Medical Center, Petah-Tikva, Israel. , Rabin medical university. Dr. Alona Zer is currently providing services as Professor. Dr. Alona Zer has authored I145and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Alona Zer contributions have acclaimed recognition from honourable subject experts around the world.

He received Doctor of Medicine and License of general Medicine in 2001, Master of Medicine – Yonsei University College of Medicine in 2005 and Specialist in Medicine in 2006.He was awarded Boryeong Research Award(Korean Society of Medical Oncology) and Exellence Award for Prolific Research(Yonsei University College of Medicine) in 2017 .2017 The Best Professor Award (International Cooperation)(Severance Hospital, Yonsei University College of Medicine) and 51stYuhan Medical Award (Excellence Award) in 2018. He is an Active member of Lung Cancer and Head & Neck Cancer Committee of KCSG.

3


Emad DawoodTawam Hospital, UAE Dr.Emad Anwar Dawoud, MD, PhD is a Consultant Clinical Oncology at Tawam Hospital (Affiliated with Johns Hopkins) Al Ain, UAE

Dr.Fathi Al Azribi is a Consultant Medical Oncologist & Division Chief at Tawam Hospital Medical Oncology Fellowship Program Director.

Hassan Jaafar , M.D., is Hemato-Oncology Consultant of Oncology Center.His Major areas of interests are including breast cancer and gynecological cancers, lung cancer, colorectal cancer, sarcomas, and all other solid tumors. He has overall 26 years of professional experience. After receiving medical degree from Medical School Al-Mustanseria University, he had 3 years of residency in Internal Medicine, Makassed General Hospital affiliated with American University of Beirut and 3 years of fellowship Hematology-Oncology American University of Beirut.

Fathi AzribiTawam Hospital, UAE

Hassan JafferSheikh Khalifa Specialty Hospital, UAE

4


John R GosneyLiverpool University Hospitals, UK

Professor John Gosney is a Consultant Thoracic Pathologist at Liverpool University Hospitals and Professor of Thoracic Pathology at the University of Liverpool. He also holds a Visiting Professorship in Thoracic Pathology at Charles University, Prague, Czech Republic. He has published over 150 research papers in peer-reviewed journals and written numerous reviews and chapters in books. He is a President of the Association of Pulmonary Pathologists. He works widely with the pharmaceutical and diagnostics industries advising on the development and application of diagnostics to the targeted therapy of lung cancer. In 2017, he received a Lifetime Achievement Award from the British Thoracic Oncology Group for his contribution to thoracic oncology.

He is currently the President and convener of Indian Cooperative Oncology Network (ICON).He has so far published over a hundred research and review articles/papers in journals of national and international repute.He has so far undertaken over 80 projects as Principal Ivestigator and Co-Investigator.He is a member of many international and national scientific societies and associations and has delivered talks in several conferences.

Dr. Kaltar Das is a Senior Specialist Medical Oncologist at Dubai Hospital, Dubai, UAE

Kaltar DasDubai Hospital, UAE

Kumar PrabhashTata Memorial Hospital, India

5


Maroun El KhouryAmerican Hospital Dubai, UAE

Maximilian HochmairOtto-Wagner Hospital, Austria

Dr. Maroun El Khoury completed his basic medical training from Saint Joseph University Schoolof Medicine Beirut, Lebanon in 1999. He is also a member of the American Society of ClinicalOncology, American Society of Hematology and American Academy of Pain Management. Dr. Maroun El Khoury›s specialty is Oncology and currently work as a Consultant Oncologist.

Dr.Mohsen Mokhtar is a professor of clinical oncology in Al-Kasr Al-Aini Medical School. Dr.Mokhtar has more than 20 years of experience in hospital management and he is currently the chief medical director in Elaj group covering the clinical and medical audit of group facilities. He is now focusing on clinical trials in breast, gynecological and prostate cancers.He is an active member of the Arab Medical Association Against Cancer (AMAAC), the Egyptian Cancer Society (ECS) and the Egyptian Hemato- Oncology Group (EHOG).

Maximilian Hochmair is an oncologist at Otto-Wagner Hospital, Austria

Mohsen MokhtarCairo University Kasr El Aini Medical School, Egypt

6


Nouri BenniniTawam Hospital, UAENouri Bennini has served as Consultant Oncologist at the Tawam Hospital in Al Ain, United Arab Emirates, since 1999. He received his general medicine diploma in 1988 from the University of Constantine in Algeria and undertook residency in medical oncology at the University of Bordeaux, France. At the University of Montpellier, France, Dr. Bennini specialised in breast diseases. He has published several scientific papers and contributed to a number of oncology conferences.

Dr.Nitesh Rohatgi is a senior consultant in Medical Oncology at Max Hospital in Saket, who was till recently working at the prestigious London Oncology Clinic (Leaders in Oncology care), Harley Street, London. He is a fellow of the Royal Society of medicine and has much publication to his name. He was trained in medical oncology, palliative medicine and teenage young adult’s cancers in United Kingdom.

Professor Popat has both a private and an NHS practice at The Royal Marsden. Professor Sanjay Popat is a Consultant Thoracic Medical Oncologist at The Royal Marsden and Honorary Clinical Senior Lecturer in the Molecular Genetics and Genomics Group at the National Heart and Lung Institute, Imperial College London.He is a specialist thoracic oncologist, and is an internationally recognised expert in the treatment of lung cancer, mesothelioma and cancers of the thymus (thymoma and thymic carcinoma).

Nitesh RohatgiMax Hospital, India

Sanjay PopatThe Royal Marsden, UK

7


Solange PetersCentreHospitalier Universitaire Vaudois, Switzerland

Srinivas ChilukuriApollo Proton Cancer Centre, India

Ullas BatraRajiv Gandhi Cancer Institute, India

Prof. Peters is currently in charge of teaching and patient care in the area of medical oncology and thoracic malignancies at the Department of Oncology of Lausanne University, where she is building a translational programme in collaboration with the molecular oncology laboratory directed by Prof. D. Hanahan and Prof. E. Meylan in Swiss Federal Institute of Technology in Lausanne and the Ludwig Institute. Prof. Peters’ main field of interest is new biomarker discovery and validation in preclinical and clinical settings.Prof. Solange Peters is an active member of the educational programme within ESMO. Prof. Peters is currently President (2021 – 2020) of the European Society for Medical Oncology (ESMO) and a member of the ESMO Faculty for Lung and Other Thoracic Cancers.

Dr. Ullas Batra obtained his DM in Medical Oncology from the prestigious Kidwai Memorial Institute of Oncology. He has gained widespread experience in the management of various malignancies like Lung cancer, breast cancer, GI Cancers and hematological malignancies etc. He has also done preceptorship in various International Institutes like MD Anderson Cancer Centre, USA, Royal Adelaide Hospital, Australia.He has participated as a Principal investigator and co-Investigator in various phase II and III clinical trials.

Dr. Srinivas Chilukuri MBBS, MD, PDCR is an Radiation Oncologist Apollo Proton Cancer Centre, India

8


Excellence in Oncology Care | cancercongress.ae


17:00 – 17:10 Opening RemarkSpeaker: Kumar Prabhash, India

17:12 – 17:45 Session 1Session Chair: Kumar Prabhash, India

17:12 – 17:27 Liquid Biopsy – State of Art in Lung CancerSpeaker: Byoung Chul Cho, South Korea

17:30 – 17:45 Advances in Proton Therapy in Lung CancerSpeaker: Srinivas Chilukuri, India

17:47 – 19:30 Session 2Session Chair: Kaltar Das, UAE

17:47 – 18:02 ASCO/ESMO Update of Targeted Therapy in Lung Cancer Speaker: Mohsen Mokhtar, Egypt

18:04 – 18:24 1L EGFR mNSCLC Management UpdateSpeaker: Maximilian Hochmair, Austria

18:26 – 18:36 Beyond EGFR Mutations – What are the OptionsSpeaker: Sanjay Popat, UK

18:38 – 19:08 Panel DiscussionModerator: Ullas Batra, India Panel: Sanjay Popat, UK | Kumar Prabhash, India | Kaltar Das, UAE Alona Zer, Israel | Maximilian Hochmair, Austria | Rajiv Kaushal, India

19:10 – 19:30 Genomic Alterations in NSCLC and TCSpeaker: John R Gosney, UK

Supported By: Apollo

Supported By: Lilly

LUNG CANCER SESSION PROGRAMFRIDAY, October 16, 2020

17:00 Hrs – 21:10 Hrs UAE Time

Supported By: NewBridge

Supported By: Lilly

9


Excellence in Oncology Care | cancercongress.ae


19:32 – 20:55 Session 3Session Chair: Hassan Jaffer, UAE | Emad Dawoud, UAE

19:32 – 19:47 ASCO/ESMO Update of Immunotherapy in Lung Cancer Speaker: Sanjay Popat, UK

19:49 – 20:04 Challenges and Treatment Approaches in Management of ES-SCLC:Evaluating New Approaches to Improve OutcomesSpeaker: Sanjay Popat, UK

20:06 – 20:16 CheckMate 227Speaker: Solange Peters, Switzerland

20:18 – 20:33 Long Term Outcomes with Checkpoint Inhibitors in NSCLCSpeaker: Alfredo Addeo, Switzerland

20:35 – 21:05 Panel DiscussionModerator: Nitesh Rohatgi, IndiaPanel: Sanjay Popat, UK | Alona Zer, Israel | Solange Peters, SwitzerlandMohsen Mokhtar, Egypt | Emad Dawoud, UAE | Fathi Azribi, UAEMaroun Khoury, UAE | Nouri Bennini, UAE

21:05 – 21:10 Question & Answers

Closing Remark

Supported by: AstraZeneca

Supported by: MSD

LUNG CANCER SESSION PROGRAMFRIDAY, October 16, 2020

17:00 Hrs – 21:10 Hrs UAE Time

10


Documents

Lung Cancer Session · lung cancer, colorectal cancer, sarcomas, and all other solid tumors. He has overall 26 years of professional experience. ... an internationally recognised